Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy

PHASE1UnknownINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

September 15, 2023

Study Completion Date

August 15, 2024

Conditions
Drug-resistant Focal EpilepsyEpilepsyEpilepsies, FocalFocal EpilepsyDrug Resistant
Interventions
PROCEDURE

Laser technology for intracerebral thermocoagulation

One intervention : LITT (Laser Interstitial Thermal Treatment), technology that uses laser energy to thermally destroy (photo-thermal treatment) a brain injury under continuous MRI control (Validated by FDA - CE marking). The operator console + surgical laser generator + software that manages the power delivered by the laser is connected to an MRI - Provided by MEDTRONIC - FDA approved and CE certified.

Trial Locations (1)

75013

RECRUITING

Hôpital Pitié Salpêtrière, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05198882 - Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy | Biotech Hunter | Biotech Hunter